Involvement of beta 3-adrenergic receptor activation via cyclic GMP- but not NO-dependent mechanisms in human corpus cavernosum function.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12707413PMCID PMC154379
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NO‐ and haem‐independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle

  2002cited by this paper
• RhoA-mediated Ca2+ Sensitization in Erectile Function*

  2002cited by this paper
• Nitric Oxide Induces Dilation of Rat Aorta via Inhibition of Rho-Kinase Signaling

  2002cited by this paper
• cGMP-dependent protein kinase phosphorylates and inactivates RhoA.

  2001cited by this paper
• Effect of Rho-kinase inhibition on vasoconstriction in the penile circulation.

  2001cited by this paper
• Pharmacology of penile erection.

  2001cited by this paper
• NO-independent regulatory site on soluble guanylate cyclase

  2001cited by this paper
• Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway

  2001cited by this paper
• Vascular adrenoceptors: an update.

  2001cited by this paper
• Pharmacotherapy for erectile dysfunction.

  2000cited by this paper
• A standardized procedure for using human corpus cavernosum strips to evaluate drug activity.

  2000cited by this paper
• Cyclic GMP-dependent Protein Kinase Signaling Pathway Inhibits RhoA-induced Ca2+ Sensitization of Contraction in Vascular Smooth Muscle*

  2000cited by this paper
• Erectile dysfunction.

  2000cited by this paper
• Soluble guanylate cyclase and cGMP-dependent protein kinase I expression in the human corpus cavernosum

  2000cited by this paper
• Beta 3‐adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium‐derived nitric oxide in rat thoracic aorta

  1999cited by this paper
• Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro.

  1999cited by this paper
• The tissue distribution of the human β3-adrenoceptor studied using a monoclonal antibody: Direct evidence of the β3-adrenoceptor in human adipose tissue, atrium and skeletal muscle

  1999cited by this paper
• Structure and function of the beta 3-adrenergic receptor.

  1997cited by this paper
• Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway.

  1994cited by this paper
• Antibodies for the immunochemistry of the human beta 3-adrenergic receptor.

  1994cited by this paper
• Tissue distribution of beta 3-adrenergic receptor mRNA in man.

  1993cited by this paper
• Hydroxyl Radical‐Dependent Inactivation of Guanylate Cyclase in Cerebral Arterioles by Methylene Blue and by LY83583

  1993cited by this paper
• Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission.

  1992cited by this paper
• Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle.

  1990cited by this paper
• Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta.

  1985cited by this paper
• Adrenoreceptors in the human penis.

  1981cited by this paper

• Short-term effect of mirabegron on female sexual function in women with overactive bladder

  2025cites this paper
• Therapeutic Potential of the β3-Adrenergic Receptor and Its Ligands in Cardiovascular Diseases

  2025cites this paper
• Effect of Mirabegron in Men With Overactive Bladder and Erectile Dysfunction: A Prospective Observational Study

  2024cites this paper
• Therapeutic Potential of Hydrogen Sulfide in Reproductive System Disorders

  2024cites this paper
• Role of hydrogen sulfide in the male reproductive system

  2024cites this paper
• The Effects of Vibegron Add-on Therapy on Alpha 1-Blocker Therapy for Sexual Function and Overactive Bladder Symptoms in Benign Prostatic Hyperplasia: A Prospective, Open-Label Study

  2024cites this paper
• Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders

  2023cites this paper
• Mirabegron-Induced Smooth Muscle Relaxation: Review of the Suggested Mechanisms

  2023cites this paper
• Comparative Study Between Behavior Therapy and Behavior Therapy Plus Mirabegron 50 mg in Sexually Active Men With Bothersome Overactive Bladder Symptoms – A Multicenter, Randomized Study

  2023cites this paper
• The bitter taste receptor (TAS2R) agonist denatonium promotes a strong relaxation of rat corpus cavernosum.

  2023cites this paper
• Conservative Non-surgical Options for Erectile Dysfunction

  2022cites this paper
• Mirabegron for treatment of erectile dysfunction concomitant with lower urinary tract symptoms in patients with benign prostatic obstruction: A randomized controlled trial

  2022cites this paper
• In vitro inhibition of phosphodiesterase type 4 enhances rat corpus cavernosum nerve-mediated relaxation induced by gasotransmitters.

  2022cites this paper
• Mirabegron improves erectile function in men with overactive bladder and erectile dysfunction: a 12-week pilot study

  2021cites this paper
• Pharmacology of Adrenaline, Noradrenaline, and Their Receptors

  2020cites this paper
• Pharmacology and perspectives in erectile dysfunction in man.

  2020cites this paper
• Effect of mirabegron on erectile function in sexually active men with bothersome overactive bladder symptoms

  2019cites this paper
• Cardiovascular effects of Micromeria graeca (L.) Benth. exRchb in normotensive and hypertensive rats.

  2019cites this paper
• Mirabegron elicits rat corpus cavernosum relaxation and increases in vivo erectile response.

  2019cites this paper
• Cardioprotective Effects of Beta3-Adrenergic Receptor (β3-AR) Pre-, Per-, and Post-treatment in Ischemia–Reperfusion

  2019cites this paper
• Mirabegron, A Selective β3-Adrenoceptor Agonist Causes an Improvement in Erectile Dysfunction in Diabetic Rats

  2019cites this paper
• The effect of mirabegron, used for overactive bladder treatment, on female sexual function: a prospective controlled study

  2018influential citation
• Mecanismo de Frank Starling: una visión aplicada en la erección del pene

  2018cites this paper
• In vitro evaluation of nebivolol effects on nonadrenergic noncholinergic responses in rabbit corpus cavernosum

  2018cites this paper
• &bgr;3 adrenergic receptor activation relaxes human corpus cavernosum and penile artery through a hydrogen sulfide/cGMP‐dependent mechanism

  2017influential citation
• Mirabegron causes relaxation of human and rat corpus cavernosum: could it be a potential therapy for erectile dysfunction?

  2016cites this paper
• Relaxing Mechanism of Gami-Shinkiwhan in Corpus Cavernosum Smooth Muscle

  2016cites this paper
• The Effect of LUTS/BPH and Treatments on Ejaculatory Function

  2016cites this paper
• Hydrochlorothiazide Potentiates Contractile Activity of Mouse Cavernosal Smooth Muscle

  2016cites this paper
• Erectogenic and Aphrodisiac Property of Moringa oleifera: Involvement of Soluble Epoxide Hydrolase Enzyme

  2016cites this paper
• The expression of β3‐adrenoceptors and their function in the human prostate

  2016cites this paper
• Factores que influyen en la respuesta a los inhibidores de la fosfodiesterasa tipo cinco en monoterapia frente a tratamiento combinado en el tratamiento de la disfunción eréctil

  2015cites this paper
• The Adrenergic System in Vascular Smooth Muscle

  2015cites this paper
• Molecular mechanisms that underlie the sexual stimulant actions of Avicennia marina (Forssk.) Vierh. and Crocus sativus L.

  2015cites this paper
• The beta‐3 adrenoceptor agonist, mirabegron relaxes isolated prostate from human and rabbit: New therapeutic indication?

  2015cites this paper
• The Cardiovascular Adrenergic System

  2015cites this paper
• Treatment of erectile dysfunction: new targets and strategies from recent research.

  2014cites this paper
• University of Groningen β3-Adrenoceptor detection and signal transduction: focus on antibody validation and urinary bladder

  2014cites this paper
• BPH/LUTS and ED: common pharmacological pathways for a common treatment.

  2013cites this paper
• The role of isoforms of soluble guanylyl cyclase in relaxation of vascular smooth muscle cells and corpora cavernosa

  2012cites this paper
• The relaxation effect and mechanism of action of higenamine in the rat corpus cavernosum

  2012cites this paper
• Hydrogen sulphide in heart and systemic circulation.

  2011cites this paper
• New therapeutic targets for the treatment of erectile dysfunction.

  2011cites this paper
• Exploration of therapeutic targets for sexual dysfunctions: lessons learned from the failed stories

  2011cites this paper
• Beta3-adrenergic receptors in cardiac and vascular tissues emerging concepts and therapeutic perspectives.

  2010cites this paper
• Tissue functions mediated by β3-adrenoceptors—findings and challenges

  2010cites this paper
• Urotensin II: a novel target in human corpus cavernosum.

  2010cites this paper
• Beta 3 adrenergic receptors: molecular, histological, functional and pharmacological approaches.

  2009cites this paper
• Hydrogen sulfide as a mediator of human corpus cavernosum smooth-muscle relaxation

  2009cites this paper
• Role of β3‐adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis

  2009cites this paper
• Beta 3 adrenergic receptors: molecular, histological, functional and pharmacological approaches

  2009cites this paper
• Effect of hemin and carbon monoxide releasing molecule (CORM-3) on cGMP in rat penile tissue.

  2008cites this paper
• Stickstoffmonoxid, erektile Dysfunktion und die Behandlung mit Betablockern (MR NOED-Studie): Vorteil von Nebivolol gegenüber Metoprolol bei Hypertonikern

  2008cites this paper
• A review of current progress in gene and stem cell therapy for erectile dysfunction

  2008cites this paper
• Evaluation of testosterone and prolactin hormones levels in erectile dysfunction patients after single oral dose of Tadalafil

  2008cites this paper
• Nebivolol induces eNOS activation and NO-liberation in murine corpus cavernosum.

  2007cites this paper
• The function of alpha- and beta-adrenoceptors of the saphenous artery in caveolin-1 knockout and wild-type mice.

  2007cites this paper
• The function of α‐ and β‐adrenoceptors of the saphenous artery in caveolin‐1 knockout and wild‐type mice

  2007cites this paper
• Beta 3-adrenoceptors in the cardiovascular system

  2007cites this paper
• The function of a - and b -adrenoceptors of the saphenous artery in caveolin-1 knockout and wild-type mice

  2007cites this paper
• NITRIC OXIDE, ERECTILE DYSFUNCTION AND BETA‐BLOCKER TREATMENT (MR NOED STUDY): BENEFIT OF NEBIVOLOL VERSUS METOPROLOL IN HYPERTENSIVE MEN

  2007cites this paper
• Adrenergic Receptors in Clinical Medicine

  2006cites this paper
• Potential involvement of a propranolol-insensitive atypical beta-adrenoceptor the vasodilator effect of cyanopindolol in the human pulmonary artery.

  2006cites this paper
• Phosphodiesterase type 5 inhibitor sildenafil citrate does not potentiate the vasodilative properties of nebivolol in rat aorta.

  2006cites this paper
• β3-Adrenoceptors in the cardiovascular system: Putative roles in human pathologies

  2006cites this paper
• Pharmacology of erectile dysfunction in man.

  2006cites this paper
• Comparison of effects of formoterol and BRL 37344 on isolated term-pregnant rat myometrial strips in vitro.

  2006cites this paper
• POTENTIAL INVOLVEMENT OF A PROPRANOLOL-INSE NSITIVE

  2006cites this paper
• beta3-adrenoceptors in the cardiovascular system: putative roles in human pathologies.

  2006cites this paper
• Nitric oxide and penile erectile function.

  2005cites this paper
• Effects of Nitric Oxide Synthase and Heme Oxygenase Inducers and Inhibitors on Molecular Signaling of Erectile Function

  2005cites this paper
• Ligands at beta2-, beta3-, and the low-affinity state of beta1-adrenoceptors block the alpha1-adrenoceptor-mediated constriction in human pulmonary and rat mesenteric arteries.

  2005cites this paper
• Ligands at β2-, β3-, and the Low-Affinity State of β1-Adrenoceptors Block the α1-Adrenoceptor-Mediated Constriction in Human Pulmonary and Rat Mesenteric Arteries

  2005cites this paper
• Mechanistic insights into the role of alpha1adrenergic receptors in lower urinary tract symptoms.

  2004cites this paper
• RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: A mechanism for diabetes-associated erectile dysfunction

  2004cites this paper
• Atypical β-Adrenoceptor Subtypes Mediate Relaxations of Rabbit Corpus Cavernosum

  2004cites this paper
• Mechanistic insights into the role of α1-adrenergic receptors in lower urinary tract symptoms

  2004cites this paper
• Role of Adenylate and Guanylate Cyclases in β1-, β2-, and β3-Adrenoceptor-Mediated Relaxation of Internal Anal Sphincter Smooth Muscle

  2004cites this paper
• Physiology and biochemistry of erections

  2004cites this paper